Literature DB >> 8676512

Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.

C Chartier1, E Degryse, M Gantzer, A Dieterle, A Pavirani, M Mehtali.   

Abstract

Despite recent technical improvements, the construction of recombinant adenovirus vectors remains a time-consuming procedure which requires extensive manipulations of the viral genome in both Escherichia coli and eukaryotic cells. This report describes a novel system based on the cloning and manipulation of the full-length adenovirus genome as a stable plasmid in E. coli, by using the bacterial homologous recombination machinery. The efficiency and flexibility of the method are illustrated by the cloning of the wild-type adenovirus type 5 genome, the insertion of a constitutive promoter upstream from the E3 region, the replacement of the E1 region by an exogenous expression cassette, and the deletion of the E1 region. All recombinant viral DNAS were shown to be fully infectious in permissive cells, and the modified E3 region or the inserted foreign gene was correctly expressed in the infected cells.

Entities:  

Mesh:

Year:  1996        PMID: 8676512      PMCID: PMC190422     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  Adenovirus vectors for gene expression.

Authors:  M V Chengalvala; M D Lubeck; B J Selling; R J Natuk; K H Hsu; B B Mason; P K Chanda; R A Bhat; B M Bhat; S Mizutani
Journal:  Curr Opin Biotechnol       Date:  1991-10       Impact factor: 9.740

Review 2.  Adenovirus-based expression vectors and recombinant vaccines.

Authors:  F L Graham; L Prevec
Journal:  Biotechnology       Date:  1992

3.  Plasmid-mediated lethality and plasmid multimer formation in an Escherichia coli recBC sbcBC mutant. Involvement of RecF recombination pathway genes.

Authors:  K Kusano; K Nakayama; H Nakayama
Journal:  J Mol Biol       Date:  1989-10-20       Impact factor: 5.469

4.  The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2.

Authors:  J Chroboczek; F Bieber; B Jacrot
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

Review 5.  Development of adenovirus vectors for the expression of heterologous genes.

Authors:  K L Berkner
Journal:  Biotechniques       Date:  1988 Jul-Aug       Impact factor: 1.993

6.  Rapid cloning by homologous recombination in vivo.

Authors:  P Bubeck; M Winkler; W Bautsch
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

7.  Upstream and downstream cis-acting elements for cleavage at the L4 polyadenylation site of adenovirus-2.

Authors:  A Sittler; H Gallinaro; M Jacob
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

8.  In vivo cloning of PCR products in E. coli.

Authors:  J D Oliner; K W Kinzler; B Vogelstein
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

9.  Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone.

Authors:  G Ketner; F Spencer; S Tugendreich; C Connelly; P Hieter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation.

Authors:  J H Cox; J R Bennink; J W Yewdell
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  225 in total

1.  Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro.

Authors:  K Aoki; C Barker; X Danthinne; M J Imperiale; G J Nabel
Journal:  Mol Med       Date:  1999-04       Impact factor: 6.354

2.  Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.

Authors:  C J Kuo; F Farnebo; E Y Yu; R Christofferson; R A Swearingen; R Carter; H A von Recum; J Yuan; J Kamihara; E Flynn; R D'Amato; J Folkman; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo.

Authors:  C Hofmann; P Löser; G Cichon; W Arnold; G W Both; M Strauss
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Optimization of the helper-dependent adenovirus system for production and potency in vivo.

Authors:  V Sandig; R Youil; A J Bett; L L Franlin; M Oshima; D Maione; F Wang; M L Metzker; R Savino; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

5.  Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.

Authors:  D M Shayakhmetov; T Papayannopoulou; G Stamatoyannopoulos; A Lieber
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression.

Authors:  X Wang; W Zeng; M Murakawa; M W Freeman; B Seed
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization.

Authors:  M Rosa-Calatrava; L Grave; F Puvion-Dutilleul; B Chatton; C Kedinger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

9.  Construction of adenoviral vectors.

Authors:  A R Davis; N A Wivel; J L Palladino; L Tao; J M Wilson
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

10.  Microtubule-independent motility and nuclear targeting of adenoviruses with fluorescently labeled genomes.

Authors:  J B Glotzer; A I Michou; A Baker; M Saltik; M Cotten
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.